Representative image
').insertAfter(".article-content__img");$(".article-content__img div").find('div').remove();
Sun Pharmaceuticals Launches Drug For Advanced Breast Cancer Patients
Sun Pharmaceutical on Wednesday launched a novel anti-cancer drug Palbociclib under the brand name of Palenotm for patients with advanced breast cancer.
Topics
Sun Pharma | breast cancer | Pharmaceutical companies
Sun Pharmaceutical on Wednesday launched a novel anti-cancer drug Palbociclib under the brand name of Palenotm for patients with advanced breast cancer.
The company said the generic drug will be available in 75, 100, 125 mgs.
Kirti Ganorkar, chief executive of Sun Pharma's domestic business, said the new drug will be priced at an affordable rate but did not disclose the same. Palenotm will address the treatment needs of several advanced breast cancer patients.
The company will also introduce a patient assistance programme that will improve patient compliance and accessibility, Ganorkar added.
Palbociclib, which is a generic medicine, is approved by the USFDA, EMA and CDSCO in combination with hormonal therapies for patients with hormone receptor positive, human epidermal growth factor receptor, negative locally advanced or metastatic breast cancers.
Breast cancer affects around 0.21 million women every year. Among the total patients, around 50 per cent are hormone receptor positive, the major subtype in breast cancer.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Subscribe to Business Standard Premium
Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!
First Published: Wed, January 11 2023. 19:05 IST
RECENT NEWS
HSBC Swings The Axe At UK Wealth In An AI Push
HSBC is preparing deep job cuts across its UK wealth management arm. It plans to cut about half of its management and sp... Read more
Kraken's Owner Buys A Bank: The Lines Are Blurring
Payward, the parent company of the crypto exchange Kraken, has agreed to buy a European bank. It would be the first digi... Read more
Revoluts Australian Banking Licence Game Changer
Revolut has spent much of its life insisting that it is more than a bank. In Australia, it has now decided that becoming... Read more
The AI Bank Is Coming, But Who Controls The Risk?
Artificial intelligence is no longer something banks discuss as a distant possibility. It is already working behind the ... Read more
ClearBank UK Profit Leads To European Growth
ClearBank has spent much of the past decade building the technology and regulatory infrastructure needed to challenge so... Read more
Bank Of London Continues To Rebuild
ClearBank’s progress shows that modern clearing and banking infrastructure can become a sizeable and profitable busine... Read more